John Lambert - Net Worth and Insider Trading

John Lambert Net Worth

The estimated net worth of John Lambert is at least $4 Million dollars as of 2024-05-03. John Lambert is the Executive Vice President of Immunogen Inc and owns about 120,521 shares of Immunogen Inc (IMGN) stock worth over $4 Million. Details can be seen in John Lambert's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Lambert has not made any transactions after 2016-11-02 and currently still holds the listed stock(s).

Transaction Summary of John Lambert

To

John Lambert Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Lambert owns 1 companies in total, including Immunogen Inc (IMGN) .

Click here to see the complete history of John Lambert’s form 4 insider trades.

Insider Ownership Summary of John Lambert

Ticker Comapny Transaction Date Type of Owner
IMGN Immunogen Inc 2016-11-02 Senior Vice President

John Lambert Latest Holdings Summary

John Lambert currently owns a total of 1 stock. John Lambert owns 120,521 shares of Immunogen Inc (IMGN) as of November 2, 2016, with a value of $4 Million.

Latest Holdings of John Lambert

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMGN Immunogen Inc 2016-11-02 120,521 31.23 3,763,871

Holding Weightings of John Lambert


John Lambert Form 4 Trading Tracker

According to the SEC Form 4 filings, John Lambert has made a total of 0 transactions in Immunogen Inc (IMGN) over the past 5 years. The most-recent trade in Immunogen Inc is the acquisition of 2,775 shares on November 2, 2016, which cost John Lambert around $4,690.

Insider Trading History of John Lambert

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Lambert Trading Performance

GuruFocus tracks the stock performance after each of John Lambert's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Lambert is 14.98%. GuruFocus also compares John Lambert's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Lambert within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Lambert's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Lambert

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.89
Relative Return to S&P 500(%) -0.44

John Lambert Ownership Network

Ownership Network List of John Lambert

No Data

Ownership Network Relation of John Lambert


John Lambert Owned Company Details

What does Immunogen Inc do?

Who are the key executives at Immunogen Inc?

John Lambert is the Senior Vice President of Immunogen Inc. Other key executives at Immunogen Inc include director & Chief Executive Officer Mark J Enyedy , Chief Business Officer Stacy Ann Coen , and V.P.-Fin. & Prin. Acctg. Off. Renee Lentini .

Immunogen Inc (IMGN) Insider Trades Summary

Over the past 18 months, John Lambert made no insider transaction in Immunogen Inc (IMGN). Other recent insider transactions involving Immunogen Inc (IMGN) include a net sale of 1,058,614 shares made by Theresa Wingrove , a net sale of 301,809 shares made by Stacy Ann Coen , and a net sale of 377,001 shares made by Renee Lentini .

In summary, during the past 3 months, insiders sold 39,348 shares of Immunogen Inc (IMGN) in total and bought 0 shares, with a net sale of 39,348 shares. During the past 18 months, 4,785,085 shares of Immunogen Inc (IMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,785,085 shares.

Immunogen Inc (IMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Immunogen Inc Insider Transactions

No Available Data

John Lambert Mailing Address

Above is the net worth, insider trading, and ownership report for John Lambert. You might contact John Lambert via mailing address: C/o Immunogen, Inc., 830 Winter Street, Waltham Ma 02451.

Discussions on John Lambert

No discussions yet.